EUVIMEDEUVIMED entdecken
Crossref

SQLE-catalyzed squalene metabolism promotes mitochondrial biogenesis and tumor development in K-ras-driven cancer

Junchen Pan, Rui Liu, Wenhua Lu, Hongyu Peng, Jing Yang, Qianrui Zhang, Tiantian Yu, Bitao Huo, Xiaoying Wei, Haixi Liang, Lin Zhou, Yameng Sun und 7 weitere

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2025.217586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Junchen Pan und 18 weiteren Autor:innen. Beteiligte Einrichtung: Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongf…. Hauptthemen laut MEDLINE: Squalene, Mitochondria, Pancreatic Neoplasms, Organelle Biogenesis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is well known that activation of oncogenic K-ras alone is insufficient to drive tumor development and that additional factors are needed for full malignant transformation, but the metabolic pathways and regulatory mechanisms that facilitate K-ras-driven cancer development remain to be characterized. Here we show that SQLE, a key enzyme in cholesterol synthesis, is upregulated in K-ras-driven cancer and its high expression is correlated with poor clinical outcome. K-ras regulates SQLE expression in a biphasic manner through reactive oxygen species and MYC signaling. Surprisingly, the pro-oncogenic role of SQLE is not mediated by promoting cholesterol synthesis, but by metabolic removal of squalene and thus mitigating its suppressive effect on the PGC-1α-mediated mitochondrial biogenesis and metabolism. Genetic silencing of SQLE in pancreatic cancer cells causes an accumulation of cellular squalene, which binds to Sp1 protein and causes a formation of a tight Sp1-TFAP2E promoter DNA complex with a highly negative binding score. This aberrant squalene/Sp1/TFAP2E promoter complex hinders the expression of TFAP2E and its downstream molecule PGC-1α, leading to suppression of mitochondrial metabolism and an almost complete inhibition of tumor formation in vivo. Importantly, administration of pharmacological squalene to mice bearing pancreatic cancer xenografts could significantly inhibit tumor growth. Our study has revealed a previously unrecognized role of SQLE in regulating gene expression and mitochondrial metabolism to facilitate K-ras-driven cancer development, and identified SQLE as a novel therapeutic target for potential treatment of pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SqualeneMitochondriaPancreatic NeoplasmsOrganelle BiogenesisProto-Oncogene Proteins p21(ras)HumansAnimalsCell Line, TumorMiceSp1 Transcription FactorSignal TransductionGene Expression Regulation, NeoplasticReactive Oxygen SpeciesProto-Oncogene Proteins c-mycPromoter Regions, GeneticMice, NudePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaTranscription Factors

Stichwörter der Autor:innen

K-rasMitochondriaPGC-1αPancreatic cancerSQLESp1Squalene

Substanzen

SqualeneSp1 Transcription FactorReactive Oxygen SpeciesSP1 protein, humanPPARGC1A protein, humanProto-Oncogene Proteins p21(ras)Proto-Oncogene Proteins c-mycKRAS protein, humanPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaTranscription Factors

Autor:innen und Institutionen

  • Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng East Road, Guangzhou, China.
  • Metabolic Innovation Center, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng East Road, Guangzhou, China; Metabolic Innovation Center, Zhongsha…
  • Department of Cellular and Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng East Road, Guangzhou, China; Hainan Academy of Biomedical Sciences…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Pan, J., Liu, R., Lu, W., Peng, H., Yang, J., Zhang, Q., Yu, T., Huo, B., Wei, X., Liang, H., Zhou, L., Sun, Y., Hu, Y., Wen, S., Fu, J., Chiao, P. J., Xia, X., Liu, J., & Huang, P. (2025). SQLE-catalyzed squalene metabolism promotes mitochondrial biogenesis and tumor development in K-ras-driven cancer. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217586

Vancouver

Pan J, Liu R, Lu W, Peng H, Yang J, Zhang Q, et al. SQLE-catalyzed squalene metabolism promotes mitochondrial biogenesis and tumor development in K-ras-driven cancer. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217586

BibTeX
@article{Pan2025,
  author = {Pan, Junchen and Liu, Rui and Lu, Wenhua and Peng, Hongyu and Yang, Jing and Zhang, Qianrui and Yu, Tiantian and Huo, Bitao and Wei, Xiaoying and Liang, Haixi and Zhou, Lin and Sun, Yameng and Hu, Yumin and Wen, Shijun and Fu, Jie and Chiao, Paul J and Xia, Xiaojun and Liu, Jinyun and Huang, Peng},
  title = {SQLE-catalyzed squalene metabolism promotes mitochondrial biogenesis and tumor development in K-ras-driven cancer},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2025.217586}
}
Kostenlos starten →